Why AbbVie Could Join the M&A Mania Soon Post author:Sam Post published:January 30, 2018 Post category:BioPharma The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash. Source: BioSpace You Might Also Like Allergan Could Bank $1B by Unloading Its Anti-Infectives Biz January 17, 2018 3 Rock-Bottom Biotechs That Big Market Players are Betting On May 15, 2017 XBiotech Announces Additions To Its Scientific Advisory Board April 9, 2017